0001699493-17-000001.txt : 20170302 0001699493-17-000001.hdr.sgml : 20170302 20170302151309 ACCESSION NUMBER: 0001699493-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20170302 DATE AS OF CHANGE: 20170302 EFFECTIVENESS DATE: 20170302 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Arrakis Therapeutics, Inc. CENTRAL INDEX KEY: 0001699493 IRS NUMBER: 475064524 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-281666 FILM NUMBER: 17658355 BUSINESS ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-488-4488 MAIL ADDRESS: STREET 1: 210 BROADWAY CITY: CAMBRIDGE STATE: MA ZIP: 02139 D 1 primary_doc.xml X0707 D LIVE 0001699493 Arrakis Therapeutics, Inc. 210 BROADWAY CAMBRIDGE MA MASSACHUSETTS 02139 857-488-4488 DELAWARE None None Corporation true 2015 Michael Gilman c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Executive Officer Director Raj Parekh c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Director Russell C. Petter c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Executive Officer Alan E. Walts c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Director David Neafus c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Executive Officer Colleen Cuffaro c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Director Carolyn Green c/o Arrakis Therapeutics, Inc. 210 Broadway Cambridge MA MASSACHUSETTS 02139 Director Biotechnology Decline to Disclose 06b false 2017-02-15 true true false 0 41238467 13238466 28000001 A portion of the amount sold includes conversion of Promissory Notes. false 8 0 0 0 false Arrakis Therapeutics, Inc. /s/Michael Gilman Michael Gilman President 2017-03-02